Learning-progression job: build from the simple idea that some proteins are tethered to membranes by lipids to the full biosynthetic logic of GPI precursor assembly, membrane-side switching, transamidation, post-attachment remodeling, ER export, surface organization, disease and modern structural measurement.
Canonical boundary: this article owns how a GPI anchor is built, attached and remodeled. COPII vesicle budding owns general ER export; sphingolipid metabolism owns ceramide/S1P pathways; phosphoinositides owns PI-derived signaling identity.
Wait, What? Some Cell-Surface Proteins Do Not Cross the Membrane
A transmembrane protein usually contains a hydrophobic segment that passes through the lipid bilayer. A GPI-anchored protein can be completely different: the protein itself can remain outside the membrane while a complex glycolipid acts as the tether.
GPI anchoring is a post-translational membrane-tethering system: the cell first builds a glycolipid in the ER, then replaces a protein’s C-terminal signal peptide with that lipid anchor.
The One-Sentence Answer
Learn GPI biology by following one anchor from phosphatidylinositol through stepwise ER assembly, transamidase-mediated attachment, PGAP remodeling, ER-to-Golgi export and final presentation of the attached protein at the cell surface.
Stage 1: Begin With the Functional Problem
A cell needs several ways to keep proteins at a membrane. Transmembrane helices are one solution. Lipid anchors are another. GPI anchoring gives proteins a membrane connection without requiring the mature protein to span the bilayer.
Stage 2: Recognise the Core Architecture
The conserved core contains phosphatidylinositol, glucosamine, mannose residues and phosphoethanolamine. The phosphatidylinositol embeds in the membrane. The glycan forms a spacer. Phosphoethanolamine links the glycan to the protein’s new C terminus.
Stage 3: Assembly Starts in the Endoplasmic Reticulum
The pathway begins with phosphatidylinositol in the ER membrane. A multisubunit GPI-GlcNAc transferase complex containing PIGA and partner PIG proteins transfers N-acetylglucosamine from UDP-GlcNAc to phosphatidylinositol.
Stage 4: The First Two Reactions Occur on the Cytosolic Side
After GlcNAc is added, PIGL removes its acetyl group, producing glucosaminyl phosphatidylinositol. This early intermediate is made on the cytosolic face of the ER.
Stage 5: Topology Becomes Part of the Mechanism
Later GPI-building reactions occur on the ER-luminal side. The pathway therefore requires the lipid intermediate to change membrane leaflet. This is a useful biological lesson: in membrane biochemistry, knowing which side of a membrane a reaction occurs on can be as important as knowing the enzyme name.
Stage 6: PIGW Adds an Inositol Acyl Chain
PIGW catalyses inositol acylation. The modification helps generate a precursor competent for later maturation and attachment. It will normally be removed again after the GPI is transferred to protein.
Stage 7: Mannoses Are Added Sequentially
GPI mannosyltransferases including PIGM, PIGV and PIGB add mannose residues using dolichol-phosphate-mannose as donor. The sequence matters because later enzymes recognise products made by earlier steps.
Stage 8: Ethanolamine-Phosphate Groups Are Installed
PIGN, PIGO and related enzymes add phosphoethanolamine to specific mannose residues. One phosphoethanolamine ultimately forms the bridge to the protein.
Stage 9: The Protein Arrives With Its Own GPI-Attachment Signal
Prospective GPI-anchored proteins enter the ER through the secretory pathway. Their C termini contain a GPI-attachment signal: an omega-site region followed by a hydrophilic spacer and a hydrophobic tail. This hydrophobic segment is temporary.
Stage 10: Transamidation Replaces Protein With Lipid
The GPI transamidase complex—PIGK, PIGT, PIGS, PIGU and GPAA1—recognises the C-terminal signal. It cleaves the protein at the omega site and links the newly exposed carboxyl group to phosphoethanolamine on the preassembled GPI.
This is not ordinary proteolysis. It is a coupled cut-and-replace reaction.
Stage 11: Structure Shows How the Transamidase Works
Cryo-EM studies of human GPI transamidase resolved a five-subunit membrane complex at near-atomic resolution. The structures identify PIGK as the catalytic protease-like subunit and reveal a transmembrane cavity positioned to receive the GPI substrate. Structural biology therefore converts a pathway diagram into a physical mechanism.
Stage 12: Attachment Is Not the End
Freshly attached GPI is still immature. PGAP proteins remodel both glycan and lipid portions. This changes how efficiently the protein exits the ER and how it behaves later in membranes.
Stage 13: PGAP1 Removes the Inositol Acyl Group
PGAP1 is an ER-localised inositol deacylase. Loss of this step can delay movement of GPI-anchored proteins through the early secretory pathway. A modification that helped precursor biosynthesis must therefore be removed for efficient maturation.
Stage 14: Glycan Remodeling Creates an Export-Ready State
PGAP5 removes a side-chain phosphoethanolamine from the GPI glycan. In mammals this improves recognition by p24-family cargo receptors and supports efficient ER exit. The anchor is therefore part of the export code.
Stage 15: The Anchor’s Fatty Acids Are Remodeled Later
PGAP3 and PGAP2 participate in fatty-acid remodeling, producing GPI anchors enriched in saturated lipid chains. This changes the physical compatibility of the protein with ordered membrane environments.
Stage 16: Remodeling Links Biochemistry to Membrane Physics
Two proteins can have identical amino-acid sequences yet occupy different membrane environments if their lipid anchors differ. GPI biology is therefore a bridge between protein biochemistry and lipid phase behaviour.
Stage 17: GPI Anchors Help Organise Surface Proteins
GPI-anchored proteins can form dynamic nanoclusters and partition into cholesterol- and sphingolipid-rich membrane regions. The older idea of a single rigid ‘lipid raft’ should be replaced by a more dynamic model of transient, nanoscale membrane organisation.
Stage 18: GPI Anchors Can Support Polarised Sorting
In epithelial cells, GPI anchoring can contribute to apical delivery, but anchor identity alone is not an absolute postal code. Protein oligomerisation, lipid remodeling and cell type all influence final sorting.
Stage 19: The Anchor Is Also Cleavable
Phospholipases can release some GPI-anchored proteins from membranes. That means a protein can switch between membrane-tethered and soluble states without changing its polypeptide chain.
Stage 20: PIGA Explains a Powerful Human Disease Example
In paroxysmal nocturnal haemoglobinuria, an acquired PIGA mutation in a haematopoietic stem cell creates blood-cell clones that cannot make GPI anchors normally. Red cells consequently lose GPI-anchored complement regulators including CD55 and CD59 and become unusually vulnerable to complement-mediated haemolysis.
Stage 21: Germline GPI-Pathway Variants Produce a Different Disease Family
Inherited GPI deficiencies can arise from variants in PIGA, PIGV, PIGO, PIGN, PIGT, PGAP2, PGAP3 and other pathway genes. Neurological impairment, seizures, developmental delay and abnormal alkaline-phosphatase patterns can appear, but phenotype depends on the exact gene and residual activity.
Stage 22: Pathway Position Helps Explain Phenotype
A defect in early precursor synthesis can reduce the total number of GPI-anchored proteins. A remodeling defect can allow attachment but alter trafficking or membrane behaviour. ‘GPI deficiency’ is therefore not one molecular state.
Stage 23: Quality Control Intersects With Glycoprotein Folding
Many GPI-anchored proteins also carry N-linked glycans. Their folding can interact with the calnexin–calreticulin system before anchor processing is complete. This is a useful systems lesson: one protein can be processed simultaneously by glycan quality control and lipid-anchor quality control.
Stage 24: FLAER Provides a Functional Measurement
FLAER is a fluorescent aerolysin-derived reagent that binds GPI anchors. Flow cytometry can use FLAER together with markers such as CD55 and CD59 to detect GPI-deficient blood-cell populations. This measures the pathway’s cell-surface receiver, not just transcript abundance.
Stage 25: Mass Spectrometry Can Analyse Anchor Composition
Specialised glycomic and lipidomic workflows can resolve GPI glycan and lipid structures. Such methods matter because ‘GPI present’ does not tell us whether remodeling was chemically correct.
Stage 26: Genetics Separates Assembly Steps
CRISPR knockout screens and classical mutant cell lines are powerful because each missing PIG or PGAP gene traps the pathway at a different state. Surface loss, ER retention or altered lipid composition can then be mapped back to the responsible reaction.
Stage 27: Professional Reasoning Uses State, Not Labels
The professional question is not simply, ‘Does this protein have a GPI anchor?’ It is:
Which precursor-building, attachment, glycan-remodeling or lipid-remodeling state is this GPI-anchored protein in, and what measurement distinguishes those possibilities?
Misconceptions Worth Hunting
- Every membrane protein has a transmembrane helix.
- GPI is attached to proteins in the Golgi.
- The hydrophobic C-terminal signal remains in the mature protein.
- GPI attachment is the final maturation step.
- All GPI anchors have identical lipid chains.
- GPI anchoring alone guarantees apical sorting.
- All GPI-deficiency disorders arise from the same gene.
- A normal amount of protein proves normal anchor chemistry.
Transfer Check
Case 1: a protein is synthesized normally but remains in the ER because PGAP1 is defective. Does this prove the GPI was never attached? No. Attachment and post-attachment remodeling are separate steps.
Case 2: a red blood cell lacks CD55 and CD59. Could failure of an upstream GPI-biosynthesis gene explain loss of both unrelated proteins at once? Yes, because both depend on the same anchoring pathway.
Case 3: a GPI-anchored protein reaches the plasma membrane but its fatty acid composition is abnormal. Which layer is most suspicious? Post-attachment lipid remodeling rather than initial transamidation.
Model Limits
GPI structures vary among organisms and cell types. Membrane nanodomains are dynamic rather than fixed structures. Surface abundance combines synthesis, remodeling, transport, endocytosis and shedding. Disease phenotypes reflect residual pathway activity and tissue dependence. Professional interpretation therefore keeps precursor chemistry + membrane topology + attachment + remodeling + trafficking + surface receiver visible together.
Connect This to the eduKate Science Estate
- COPII Vesicle Budding and ER Export
- Sphingolipid Metabolism
- Phosphoinositides and Membrane Identity
- Ubiquitin–Proteasome System and Protein Degradation
The Quiet Ending
The beginner asks, ‘How does this protein stick to the membrane?’
The developing cell biologist asks, ‘Where was the GPI anchor assembled and when was it attached?’
The professional asks:
Which chemical state of the GPI anchor explains the protein’s trafficking, membrane behaviour and biological function in the cell we are actually measuring?
Science Hub Route
Continue through the eduKate Sengkang Science Hub · Complete Science Index
